MedTrace Logo

HSV-2 Shedding Resolution After Acyclovir Treatment

NCT00495573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2012-03-22

No results posted yet for this study

Summary

The purpose of the study is to evaluate the pattern of viral shedding after beginning treatment with acyclovir for a clinical recurrence of genital herpes and to compare it with the pattern of viral shedding during an untreated clinical recurrence of genital herpes.

Conditions

  • Genital Herpes

Interventions

DRUG

acyclovir

400 mg acyclovir, orally three times a day for 5 days

Sponsors & Collaborators

Principal Investigators

  • Anna Wald, MD, MPH · University of Washington

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2009-11-30
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00495573 on ClinicalTrials.gov